| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 1.35e-08 | 4 | 31 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.77e-06 | 188 | 31 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 6.29e-05 | 140 | 31 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | potassium channel inhibitor activity | 1.27e-04 | 11 | 31 | 2 | GO:0019870 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 4.82e-04 | 1244 | 31 | 8 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 5.56e-04 | 1271 | 31 | 8 | GO:0000987 | |
| GeneOntologyMolecularFunction | transcription factor binding | 9.26e-04 | 753 | 31 | 6 | GO:0008134 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.38e-03 | 1459 | 31 | 8 | GO:0000977 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.45e-03 | 320 | 31 | 4 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.55e-03 | 326 | 31 | 4 | GO:0001217 | |
| GeneOntologyMolecularFunction | structural molecule activity | 2.19e-03 | 891 | 31 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 2.52e-03 | 48 | 31 | 2 | GO:0008200 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 2.73e-03 | 50 | 31 | 2 | GO:0016248 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 2.84e-03 | 51 | 31 | 2 | GO:0141110 | |
| GeneOntologyMolecularFunction | potassium channel regulator activity | 3.53e-03 | 57 | 31 | 2 | GO:0015459 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 3.78e-03 | 59 | 31 | 2 | GO:0001222 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.29e-10 | 109 | 33 | 7 | GO:0005796 | |
| GeneOntologyCellularComponent | extracellular matrix | 6.09e-05 | 656 | 33 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 6.20e-05 | 658 | 33 | 7 | GO:0030312 | |
| Domain | SEA | 7.02e-09 | 14 | 32 | 4 | SM00200 | |
| Domain | SEA | 6.14e-08 | 23 | 32 | 4 | PS50024 | |
| Domain | SEA_dom | 6.14e-08 | 23 | 32 | 4 | IPR000082 | |
| Domain | VWFD | 2.52e-06 | 16 | 32 | 3 | PS51233 | |
| Domain | VWD | 2.52e-06 | 16 | 32 | 3 | SM00216 | |
| Domain | VWF_type-D | 2.52e-06 | 16 | 32 | 3 | IPR001846 | |
| Domain | VWD | 2.52e-06 | 16 | 32 | 3 | PF00094 | |
| Domain | SEA | 6.88e-06 | 22 | 32 | 3 | PF01390 | |
| Domain | Kinase_OSR1/WNK_CCT | 4.25e-05 | 6 | 32 | 2 | IPR024678 | |
| Domain | OSR1_C | 4.25e-05 | 6 | 32 | 2 | PF12202 | |
| Domain | TIL | 1.86e-04 | 12 | 32 | 2 | PF01826 | |
| Domain | C8 | 1.86e-04 | 12 | 32 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 2.19e-04 | 13 | 32 | 2 | IPR014853 | |
| Domain | C8 | 2.19e-04 | 13 | 32 | 2 | SM00832 | |
| Domain | TIL_dom | 2.55e-04 | 14 | 32 | 2 | IPR002919 | |
| Domain | - | 2.94e-04 | 15 | 32 | 2 | 3.30.70.960 | |
| Domain | VWC_out | 4.78e-04 | 19 | 32 | 2 | SM00215 | |
| Domain | CT | 6.43e-04 | 22 | 32 | 2 | SM00041 | |
| Domain | EGF_3 | 6.66e-04 | 235 | 32 | 4 | PS50026 | |
| Domain | EGF | 6.66e-04 | 235 | 32 | 4 | SM00181 | |
| Domain | EGF-like_dom | 8.27e-04 | 249 | 32 | 4 | IPR000742 | |
| Domain | Cys_knot_C | 8.32e-04 | 25 | 32 | 2 | IPR006207 | |
| Domain | CTCK_2 | 8.32e-04 | 25 | 32 | 2 | PS01225 | |
| Domain | EGF_1 | 9.03e-04 | 255 | 32 | 4 | PS00022 | |
| Domain | EGF-like_CS | 9.85e-04 | 261 | 32 | 4 | IPR013032 | |
| Domain | EGF_2 | 1.04e-03 | 265 | 32 | 4 | PS01186 | |
| Domain | VWF_dom | 2.35e-03 | 42 | 32 | 2 | IPR001007 | |
| Domain | Kinase-like_dom | 1.32e-02 | 542 | 32 | 4 | IPR011009 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.29e-13 | 16 | 25 | 6 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.99e-13 | 17 | 25 | 6 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.61e-12 | 23 | 25 | 6 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.66e-12 | 26 | 25 | 6 | M27483 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.29e-10 | 21 | 25 | 5 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 9.37e-10 | 62 | 25 | 6 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.66e-09 | 68 | 25 | 6 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.26e-08 | 111 | 25 | 6 | M27416 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.86e-08 | 60 | 25 | 5 | MM15636 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.31e-07 | 140 | 25 | 6 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.48e-07 | 143 | 25 | 6 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.18e-06 | 109 | 25 | 5 | MM15164 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.91e-06 | 250 | 25 | 6 | M27554 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 6.12e-04 | 95 | 25 | 3 | M48268 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 1.72e-03 | 297 | 25 | 4 | M27050 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.77e-03 | 137 | 25 | 3 | M48232 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 2.75e-03 | 1128 | 25 | 7 | M1036 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 8.30e-15 | 18 | 33 | 6 | 18834073 | |
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 10512748 | ||
| Pubmed | 1.55e-08 | 6 | 33 | 3 | 19110483 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 9334251 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 12958310 | ||
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 8.73e-07 | 2 | 33 | 2 | 2393399 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 11289722 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 23544943 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 14690056 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 28649694 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 8.73e-07 | 2 | 33 | 2 | 10973822 | |
| Pubmed | WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia. | 8.73e-07 | 2 | 33 | 2 | 35849656 | |
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 8.73e-07 | 2 | 33 | 2 | 10405327 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 20065027 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23446997 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23053434 | ||
| Pubmed | Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression. | 2.62e-06 | 3 | 33 | 2 | 23305535 | |
| Pubmed | Wnk kinases are positive regulators of canonical Wnt/β-catenin signalling. | 2.62e-06 | 3 | 33 | 2 | 23797875 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 27230679 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 30236127 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 35879412 | ||
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 2.62e-06 | 3 | 33 | 2 | 18163520 | |
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 2.62e-06 | 3 | 33 | 2 | 17592322 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 27483328 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 24204560 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 24939955 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 21596555 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 23807779 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 34384519 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 17471237 | ||
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 5.23e-06 | 4 | 33 | 2 | 39024979 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 14984930 | ||
| Pubmed | Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. | 5.23e-06 | 4 | 33 | 2 | 18198997 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 12676567 | ||
| Pubmed | WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. | 5.23e-06 | 4 | 33 | 2 | 11571656 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 11498583 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 5.23e-06 | 4 | 33 | 2 | 29869461 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 8.72e-06 | 5 | 33 | 2 | 11062147 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 24840470 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 18035521 | ||
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 8.72e-06 | 5 | 33 | 2 | 16475027 | |
| Pubmed | WNK2 kinase is a novel regulator of essential neuronal cation-chloride cotransporters. | 1.31e-05 | 6 | 33 | 2 | 21733846 | |
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 20525693 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.91e-05 | 351 | 33 | 5 | 38297188 | |
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 23387299 | ||
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 23838290 | ||
| Pubmed | The blood vasculature instructs lymphatic patterning in a SOX7-dependent manner. | 2.44e-05 | 8 | 33 | 2 | 36715213 | |
| Pubmed | Sox7-positive endothelial progenitors establish coronary arteries and govern ventricular compaction. | 3.13e-05 | 9 | 33 | 2 | 37551717 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.49e-05 | 398 | 33 | 5 | 35016035 | |
| Pubmed | CCBE1 Is Essential for Epicardial Function during Myocardium Development. | 3.91e-05 | 10 | 33 | 2 | 36293499 | |
| Pubmed | Genetic loci influencing kidney function and chronic kidney disease. | 4.78e-05 | 11 | 33 | 2 | 20383145 | |
| Pubmed | 6.02e-05 | 225 | 33 | 4 | 12168954 | ||
| Pubmed | 7.89e-05 | 14 | 33 | 2 | 16452088 | ||
| Pubmed | Loss of Tbx2 delays optic vesicle invagination leading to small optic cups. | 7.89e-05 | 14 | 33 | 2 | 19576202 | |
| Pubmed | Sox7, Sox17, and Sox18 Cooperatively Regulate Vascular Development in the Mouse Retina. | 9.10e-05 | 15 | 33 | 2 | 26630461 | |
| Pubmed | Lack of Genetic Interaction between Tbx18 and Tbx2/Tbx20 in Mouse Epicardial Development. | 1.04e-04 | 16 | 33 | 2 | 27253890 | |
| Pubmed | 1.04e-04 | 16 | 33 | 2 | 27856909 | ||
| Pubmed | 1.18e-04 | 268 | 33 | 4 | 33640491 | ||
| Pubmed | TBX2-positive cells represent a multi-potent mesenchymal progenitor pool in the developing lung. | 1.48e-04 | 19 | 33 | 2 | 31870435 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.52e-04 | 544 | 33 | 5 | 28473536 | |
| Pubmed | Sox17 is indispensable for acquisition and maintenance of arterial identity. | 1.64e-04 | 20 | 33 | 2 | 24153254 | |
| Pubmed | 1.64e-04 | 20 | 33 | 2 | 33665565 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.89e-04 | 908 | 33 | 6 | 19274049 | |
| Pubmed | 2.18e-04 | 23 | 33 | 2 | 28811219 | ||
| Pubmed | E-cadherin is required for intestinal morphogenesis in the mouse. | 2.38e-04 | 24 | 33 | 2 | 22766025 | |
| Pubmed | 2.58e-04 | 25 | 33 | 2 | 33846290 | ||
| Pubmed | 3.25e-04 | 1429 | 33 | 7 | 35140242 | ||
| Pubmed | 4.06e-04 | 152 | 33 | 3 | 38360978 | ||
| Pubmed | Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. | 4.53e-04 | 33 | 33 | 2 | 16618389 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 5.39e-04 | 1105 | 33 | 6 | 35748872 | |
| Pubmed | 6.11e-04 | 175 | 33 | 3 | 28071719 | ||
| Pubmed | Tbx2 controls lung growth by direct repression of the cell cycle inhibitor genes Cdkn1a and Cdkn1b. | 6.33e-04 | 39 | 33 | 2 | 23341776 | |
| Pubmed | 6.39e-04 | 418 | 33 | 4 | 34709266 | ||
| Pubmed | 7.00e-04 | 41 | 33 | 2 | 22675208 | ||
| Pubmed | Arid3b is essential for second heart field cell deployment and heart patterning. | 7.69e-04 | 43 | 33 | 2 | 25336743 | |
| Pubmed | 8.80e-04 | 46 | 33 | 2 | 19190083 | ||
| Pubmed | 9.19e-04 | 47 | 33 | 2 | 11208732 | ||
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 9.26e-04 | 202 | 33 | 3 | 33601422 | |
| Cytoband | 7q22 | 3.47e-04 | 38 | 33 | 2 | 7q22 | |
| Cytoband | 19p13.2 | 5.98e-04 | 229 | 33 | 3 | 19p13.2 | |
| Cytoband | 11p15.5 | 3.28e-03 | 118 | 33 | 2 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq28 | 1.03e-02 | 213 | 33 | 2 | chrXq28 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 1.09e-02 | 219 | 33 | 2 | chr7q22 | |
| GeneFamily | CD molecules|Mucins | 7.70e-19 | 21 | 25 | 8 | 648 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.93e-03 | 181 | 25 | 3 | 694 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.25e-09 | 170 | 32 | 7 | M5880 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.47e-08 | 158 | 32 | 6 | MM17063 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 2.50e-06 | 751 | 32 | 8 | M5885 | |
| Coexpression | NABA_MATRISOME | 2.59e-06 | 1026 | 32 | 9 | M5889 | |
| Coexpression | NABA_MATRISOME | 2.15e-05 | 1008 | 32 | 8 | MM17056 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 2.48e-05 | 738 | 32 | 7 | MM17058 | |
| Coexpression | TRAVAGLINI_LUNG_GOBLET_CELL | 3.10e-05 | 148 | 32 | 4 | M41655 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | 9.81e-05 | 199 | 32 | 4 | M5268 | |
| Coexpression | GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN | 1.00e-04 | 200 | 32 | 4 | M9763 | |
| Coexpression | DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS | 2.25e-04 | 97 | 32 | 3 | M40301 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.32e-06 | 89 | 31 | 4 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k1_1000 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.34e-11 | 179 | 32 | 7 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.51e-11 | 180 | 32 | 7 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.51e-11 | 180 | 32 | 7 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 5.27e-11 | 184 | 32 | 7 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 3.46e-09 | 183 | 32 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.89e-07 | 182 | 32 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.53e-07 | 193 | 32 | 5 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.00e-06 | 159 | 32 | 4 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.25e-06 | 161 | 32 | 4 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.65e-06 | 164 | 32 | 4 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | Club_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.93e-06 | 166 | 32 | 4 | a440aa338aa0c6cd0b5800dfa7e83f8ca16fce1a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-06 | 167 | 32 | 4 | 31633899aae852873a4887e72c621474b0a51a33 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.98e-06 | 173 | 32 | 4 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.98e-06 | 173 | 32 | 4 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.98e-06 | 173 | 32 | 4 | e8afef5ae68983eb8d6515b43952636a47e9d3d4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.98e-06 | 173 | 32 | 4 | 3aa1d28d4814798a772808ed29e1dbbdf92abd03 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.14e-06 | 174 | 32 | 4 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.14e-06 | 174 | 32 | 4 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.64e-06 | 177 | 32 | 4 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.64e-06 | 177 | 32 | 4 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.81e-06 | 178 | 32 | 4 | fce60ce6b662f1bdaa3b4da43800c6c22fe89533 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.81e-06 | 178 | 32 | 4 | b19c906e067b07eadfd68934d9330b447e24c708 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.99e-06 | 179 | 32 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 8.71e-06 | 183 | 32 | 4 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.90e-06 | 184 | 32 | 4 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 9.29e-06 | 186 | 32 | 4 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.49e-06 | 187 | 32 | 4 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.69e-06 | 188 | 32 | 4 | 07705bed928683470a52c8ccfa40ffb9a0971318 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.69e-06 | 188 | 32 | 4 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 9.89e-06 | 189 | 32 | 4 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 1.01e-05 | 190 | 32 | 4 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.01e-05 | 190 | 32 | 4 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | IPF-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 1.01e-05 | 190 | 32 | 4 | c29dabf0826663b9d6df51a7af9b76592090e44c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 190 | 32 | 4 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 190 | 32 | 4 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-05 | 191 | 32 | 4 | 30e7cc5f7eadf90ab0900a73fdfe48f9a1adcbfb | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-05 | 191 | 32 | 4 | 41d2f5278f6d5f52a5bdf4f3df70969481c00162 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 192 | 32 | 4 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 1.05e-05 | 192 | 32 | 4 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-05 | 193 | 32 | 4 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.07e-05 | 193 | 32 | 4 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-05 | 193 | 32 | 4 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.07e-05 | 193 | 32 | 4 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-05 | 194 | 32 | 4 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 194 | 32 | 4 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.12e-05 | 195 | 32 | 4 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-05 | 195 | 32 | 4 | b9e8f405f6d837bb39b615836d3e2df349737c0e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-05 | 195 | 32 | 4 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-05 | 196 | 32 | 4 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.14e-05 | 196 | 32 | 4 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-05 | 196 | 32 | 4 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.14e-05 | 196 | 32 | 4 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 1.14e-05 | 196 | 32 | 4 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-05 | 196 | 32 | 4 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 197 | 32 | 4 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.16e-05 | 197 | 32 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 197 | 32 | 4 | 19cf283537c853fa902852e7b8ac1139729a931a | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 197 | 32 | 4 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 197 | 32 | 4 | e14a0e8a893c72356afc5508e3531ae0b23bfe16 | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.16e-05 | 197 | 32 | 4 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 197 | 32 | 4 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.19e-05 | 198 | 32 | 4 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-05 | 198 | 32 | 4 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-05 | 198 | 32 | 4 | 1fe60443c11d34b6d2671af8f06e0dedc8d1558b | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-05 | 198 | 32 | 4 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-05 | 198 | 32 | 4 | 9c0535099750698daac5d6b4d39fb19fecf4ffde | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.19e-05 | 198 | 32 | 4 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-05 | 198 | 32 | 4 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.19e-05 | 198 | 32 | 4 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.19e-05 | 198 | 32 | 4 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-05 | 198 | 32 | 4 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-05 | 198 | 32 | 4 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 32 | 4 | 70c0b9cff195d3d24e98443a729e211cac20c90f | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5B+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.21e-05 | 199 | 32 | 4 | afd0df242a93f176438309668a9487be1250d9ca | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 32 | 4 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 32 | 4 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5AC+_High|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.21e-05 | 199 | 32 | 4 | a5240868cea40574ed4ee45eb27a00c1812957ed | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.24e-05 | 200 | 32 | 4 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 200 | 32 | 4 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Lung_Parenchyma-Severe|Lung_Parenchyma / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.24e-05 | 200 | 32 | 4 | 62502bb23ca732daed32c838ce9719093f3aaeb0 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.24e-05 | 200 | 32 | 4 | 292c63693eb7f435335a8cfba07aa35b72139393 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 200 | 32 | 4 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5B+|Biopsy_IPF / Sample group, Lineage and Cell type | 1.24e-05 | 200 | 32 | 4 | f0a6747f6d37ec6d261bd649ac678c39cca5e4c8 | |
| ToppCell | distal-Endothelial-Capillary-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.24e-05 | 200 | 32 | 4 | 259f2da978380e1ba323207f16f4569106edb403 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 200 | 32 | 4 | 133853d0f55c63ebe94dd54151f9f1f90650a0d8 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-05 | 200 | 32 | 4 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.24e-05 | 200 | 32 | 4 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 200 | 32 | 4 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.07e-05 | 112 | 32 | 3 | 88fcd0dc12b5c00804381fb7dd59a6a2a9f37419 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.07e-05 | 112 | 32 | 3 | fd4cc5190626cb262aae0a7f04559b0e9757270e | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.07e-05 | 112 | 32 | 3 | d652e6fae433a6b56bf2a448fba2cf6c5e558905 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(3)_72hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.18e-04 | 133 | 32 | 3 | 32c6a00671af309c4b0b90e93549733729684c61 | |
| ToppCell | Club_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-04 | 138 | 32 | 3 | 133015953fc660d00339f47b415da5e9872313a2 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 152 | 32 | 3 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 153 | 32 | 3 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-04 | 155 | 32 | 3 | 8dab23aad905cc35a35643baa0554acb3f6fe6c8 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-04 | 155 | 32 | 3 | 42533beaded07068f00540de704de07e4f19abcf | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-SMG_basal_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.96e-04 | 158 | 32 | 3 | adad97e6cf479d42791c5ba9cbc5f15f469322bf | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.96e-04 | 158 | 32 | 3 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 158 | 32 | 3 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| Drug | cellobiitol | 1.80e-07 | 37 | 31 | 4 | CID000003871 | |
| Drug | CsCl | 1.06e-06 | 136 | 31 | 5 | CID000024293 | |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A | 6.52e-06 | 197 | 31 | 5 | 7021_UP | |
| Drug | genistein; Down 200; 10uM; MCF7; HG-U133A | 6.69e-06 | 198 | 31 | 5 | 382_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.69e-06 | 198 | 31 | 5 | 7177_DN | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 6.69e-06 | 198 | 31 | 5 | 3424_DN | |
| Drug | rioprostil | 1.10e-05 | 32 | 31 | 3 | CID005311413 | |
| Drug | guanidine hydrochloride | 2.75e-05 | 129 | 31 | 4 | CID000005742 | |
| Drug | inulin | 3.10e-05 | 133 | 31 | 4 | CID000024763 | |
| Drug | Gastrin tetrapeptide | 4.29e-05 | 50 | 31 | 3 | CID000005415 | |
| Drug | Tn epitope | 5.72e-05 | 55 | 31 | 3 | CID000447272 | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.29e-04 | 192 | 31 | 4 | 1638_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.29e-04 | 192 | 31 | 4 | 993_DN | |
| Drug | Nimodipine [66085-59-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 193 | 31 | 4 | 5421_UP | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.37e-04 | 195 | 31 | 4 | 4817_UP | |
| Drug | O-acetylated sialic acid | 1.39e-04 | 13 | 31 | 2 | CID000440038 | |
| Drug | kappa-casein glycomacropeptide | 1.39e-04 | 13 | 31 | 2 | ctd:C020251 | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 6845_UP | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 7360_DN | |
| Drug | 5162773; Down 200; 7uM; MCF7; HT_HG-U133A_EA | 1.40e-04 | 196 | 31 | 4 | 892_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 4423_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HG-U133A | 1.40e-04 | 196 | 31 | 4 | 1958_UP | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 4727_UP | |
| Drug | NS-398; Down 200; 10uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 6897_DN | |
| Drug | Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 6099_UP | |
| Drug | Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 2747_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 7138_DN | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 3126_DN | |
| Drug | D-cycloserine [68-41-7]; Up 200; 39.2uM; HL60; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 6139_UP | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 6287_DN | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; PC3; HT_HG-U133A | 1.48e-04 | 199 | 31 | 4 | 5749_UP | |
| Drug | mucic acid | 2.32e-04 | 88 | 31 | 3 | CID000000607 | |
| Disease | cholangiocarcinoma (is_marker_for) | 7.10e-11 | 64 | 32 | 6 | DOID:4947 (is_marker_for) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.14e-05 | 5 | 32 | 2 | DOID:3030 (is_marker_for) | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 1.70e-05 | 6 | 32 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 4.00e-05 | 61 | 32 | 3 | DOID:3587 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 5.10e-05 | 10 | 32 | 2 | DOID:10754 (is_marker_for) | |
| Disease | N6-acetyllysine measurement | 5.10e-05 | 10 | 32 | 2 | EFO_0800036 | |
| Disease | pancreatic cancer (is_marker_for) | 1.80e-04 | 101 | 32 | 3 | DOID:1793 (is_marker_for) | |
| Disease | 1,5 anhydroglucitol measurement | 4.54e-04 | 29 | 32 | 2 | EFO_0008009 | |
| Disease | heart rate response to exercise | 1.00e-03 | 43 | 32 | 2 | EFO_0009184 | |
| Disease | lip morphology measurement | 1.12e-03 | 189 | 32 | 3 | EFO_0007845 | |
| Disease | QRS amplitude, QRS complex | 1.35e-03 | 50 | 32 | 2 | EFO_0005054, EFO_0007742 | |
| Disease | response to tenofovir | 1.41e-03 | 51 | 32 | 2 | EFO_0009279 | |
| Disease | Autism Spectrum Disorders | 3.85e-03 | 85 | 32 | 2 | C1510586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVDQTIGTPTVTSPS | 1461 | Q8TCU4 | |
| VLISTPTPTIVRPGS | 141 | P17544 | |
| VTVTPSAPGTTTCQP | 1491 | Q9HC84 | |
| TEPTVPGVATSTLPT | 1681 | Q9HC84 | |
| GTTPIPPVLTTTATT | 2711 | Q9HC84 | |
| GTTPIPPVLTTTATT | 3411 | Q9HC84 | |
| PTTTTIQVLPTVPGS | 456 | P51610 | |
| PVSVVIPTSPTIGSS | 1416 | Q8WXI7 | |
| IPGPSQSTVLPEIST | 6996 | Q8WXI7 | |
| SVPTTSIPGTPTVDL | 13601 | Q8WXI7 | |
| SVSTGDTTPLPVTIP | 4136 | Q99102 | |
| NVVTPTTGTTPKGTI | 51 | Q9ULC0 | |
| TTPQLPTTGSRPTQV | 1206 | Q6W4X9 | |
| TVPITTTPFPTSTIG | 1896 | Q2M2H8 | |
| TIPLTTVLTNGPPAS | 421 | Q99607 | |
| IPSTVGTPIKINSSP | 1551 | Q5HYC2 | |
| VVITLPSEPGTPTDS | 2581 | Q9Y6V0 | |
| IPTSQPTTITPSSVG | 1571 | Q02505 | |
| TPTQTPPVLTSATGT | 2576 | Q02505 | |
| TTPCPGTITITIVPA | 2766 | Q02505 | |
| GTITITIVPASPTDP | 2771 | Q02505 | |
| TAPLTPVTQGPSVIT | 411 | Q9H334 | |
| VTVTVLGITTTPIPP | 341 | Q3SXY7 | |
| IGDISTSTVSTPVPP | 736 | P50570 | |
| PVNTTTSPVNVTTGP | 341 | Q3C1V0 | |
| EGISTIPSPVTSPVL | 716 | Q8NEL9 | |
| PVQGTTPQISPSTLI | 1036 | Q9UBN7 | |
| TPTPLVVTSTVTTGL | 301 | P25940 | |
| EGTTPLTSIPVSTTP | 1746 | Q685J3 | |
| PLTGVPVSTTPVTSS | 3106 | Q685J3 | |
| TPCPGTITITIVPAS | 681 | Q9H195 | |
| PVSQVTPTGPTETSL | 356 | Q9BT81 | |
| PGSVPTGPTINTTIQ | 1411 | Q9HCJ0 | |
| VGPTLQTTSVSPDPT | 391 | Q68BL8 | |
| PTAEPSGTTSVQVPT | 341 | P40967 | |
| STLTLTTIGETPPPV | 331 | Q16280 | |
| IPVTIPPSTSLLTTG | 626 | Q13207 | |
| LPLVTTPETLVQPGT | 416 | Q15569 | |
| PGLPSLTTTVVQATP | 766 | Q9ULD9 | |
| TPVVTPGQVSTPVST | 1726 | Q9H4A3 | |
| TTVIPGAAPTLSVPT | 2231 | Q9Y3S1 | |
| PTLNIIGPVQTTTSP | 591 | Q6ZS17 | |
| GSITPPQTTPLTELQ | 1391 | P15822 |